The global Valsartan Tablets market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

North American market for Valsartan Tablets is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Valsartan Tablets is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global manufacturers of Valsartan Tablets include Alembic, Cadista, Camber, Major, Mylan, Solco Healthcare, Teva, Lupin and Repackagers, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Valsartan Tablets, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Valsartan Tablets.

Report Scope

The Valsartan Tablets market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Valsartan Tablets market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Valsartan Tablets manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Valsartan Tablets Market Report

Report Metric	Details
Report Name	Valsartan Tablets Market
Segment by Type	40mg 80mg 160mg 320mg
Segment by Application	Hospital Clinic Recovery Center
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Alembic, Cadista, Camber, Major, Mylan, Solco Healthcare, Teva, Lupin, Repackagers, Aurobindo, Zhejiang Huahai Pharm, Changzhou Siyao Pharmaceutical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Valsartan Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Valsartan Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Valsartan Tablets Market report?

Ans: The main players in the Valsartan Tablets Market are Alembic, Cadista, Camber, Major, Mylan, Solco Healthcare, Teva, Lupin, Repackagers, Aurobindo, Zhejiang Huahai Pharm, Changzhou Siyao Pharmaceutical

What are the Application segmentation covered in the Valsartan Tablets Market report?

Ans: The Applications covered in the Valsartan Tablets Market report are Hospital, Clinic, Recovery Center

What are the Type segmentation covered in the Valsartan Tablets Market report?

Ans: The Types covered in the Valsartan Tablets Market report are 40mg, 80mg, 160mg, 320mg

1 Valsartan Tablets Market Overview

1.1 Product Overview and Scope of Valsartan Tablets

1.2 Valsartan Tablets Segment by Type

1.2.1 Global Valsartan Tablets Market Value Comparison by Type (2024-2030)

1.2.2 40mg

1.2.3 80mg

1.2.4 160mg

1.2.5 320mg

1.3 Valsartan Tablets Segment by Application

1.3.1 Global Valsartan Tablets Market Value by Application: (2024-2030)

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Recovery Center

1.4 Global Valsartan Tablets Market Size Estimates and Forecasts

1.4.1 Global Valsartan Tablets Revenue 2019-2030

1.4.2 Global Valsartan Tablets Sales 2019-2030

1.4.3 Global Valsartan Tablets Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Valsartan Tablets Market Competition by Manufacturers

2.1 Global Valsartan Tablets Sales Market Share by Manufacturers (2019-2024)

2.2 Global Valsartan Tablets Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Valsartan Tablets Average Price by Manufacturers (2019-2024)

2.4 Global Valsartan Tablets Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Valsartan Tablets, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Valsartan Tablets, Product Type & Application

2.7 Valsartan Tablets Market Competitive Situation and Trends

2.7.1 Valsartan Tablets Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Valsartan Tablets Players Market Share by Revenue

2.7.3 Global Valsartan Tablets Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Valsartan Tablets Retrospective Market Scenario by Region

3.1 Global Valsartan Tablets Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Valsartan Tablets Global Valsartan Tablets Sales by Region: 2019-2030

3.2.1 Global Valsartan Tablets Sales by Region: 2019-2024

3.2.2 Global Valsartan Tablets Sales by Region: 2025-2030

3.3 Global Valsartan Tablets Global Valsartan Tablets Revenue by Region: 2019-2030

3.3.1 Global Valsartan Tablets Revenue by Region: 2019-2024

3.3.2 Global Valsartan Tablets Revenue by Region: 2025-2030

3.4 North America Valsartan Tablets Market Facts & Figures by Country

3.4.1 North America Valsartan Tablets Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Valsartan Tablets Sales by Country (2019-2030)

3.4.3 North America Valsartan Tablets Revenue by Country (2019-2030)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Valsartan Tablets Market Facts & Figures by Country

3.5.1 Europe Valsartan Tablets Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Valsartan Tablets Sales by Country (2019-2030)

3.5.3 Europe Valsartan Tablets Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Valsartan Tablets Market Facts & Figures by Country

3.6.1 Asia Pacific Valsartan Tablets Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Valsartan Tablets Sales by Country (2019-2030)

3.6.3 Asia Pacific Valsartan Tablets Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Valsartan Tablets Market Facts & Figures by Country

3.7.1 Latin America Valsartan Tablets Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Valsartan Tablets Sales by Country (2019-2030)

3.7.3 Latin America Valsartan Tablets Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Valsartan Tablets Market Facts & Figures by Country

3.8.1 Middle East and Africa Valsartan Tablets Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Valsartan Tablets Sales by Country (2019-2030)

3.8.3 Middle East and Africa Valsartan Tablets Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Valsartan Tablets Sales by Type (2019-2030)

4.1.1 Global Valsartan Tablets Sales by Type (2019-2024)

4.1.2 Global Valsartan Tablets Sales by Type (2025-2030)

4.1.3 Global Valsartan Tablets Sales Market Share by Type (2019-2030)

4.2 Global Valsartan Tablets Revenue by Type (2019-2030)

4.2.1 Global Valsartan Tablets Revenue by Type (2019-2024)

4.2.2 Global Valsartan Tablets Revenue by Type (2025-2030)

4.2.3 Global Valsartan Tablets Revenue Market Share by Type (2019-2030)

4.3 Global Valsartan Tablets Price by Type (2019-2030)

5 Segment by Application

5.1 Global Valsartan Tablets Sales by Application (2019-2030)

5.1.1 Global Valsartan Tablets Sales by Application (2019-2024)

5.1.2 Global Valsartan Tablets Sales by Application (2025-2030)

5.1.3 Global Valsartan Tablets Sales Market Share by Application (2019-2030)

5.2 Global Valsartan Tablets Revenue by Application (2019-2030)

5.2.1 Global Valsartan Tablets Revenue by Application (2019-2024)

5.2.2 Global Valsartan Tablets Revenue by Application (2025-2030)

5.2.3 Global Valsartan Tablets Revenue Market Share by Application (2019-2030)

5.3 Global Valsartan Tablets Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Alembic

6.1.1 Alembic Corporation Information

6.1.2 Alembic Description and Business Overview

6.1.3 Alembic Valsartan Tablets Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Alembic Valsartan Tablets Product Portfolio

6.1.5 Alembic Recent Developments/Updates

6.2 Cadista

6.2.1 Cadista Corporation Information

6.2.2 Cadista Description and Business Overview

6.2.3 Cadista Valsartan Tablets Sales, Revenue and Gross Margin (2019-2024)

6.2.4 Cadista Valsartan Tablets Product Portfolio

6.2.5 Cadista Recent Developments/Updates

6.3 Camber

6.3.1 Camber Corporation Information

6.3.2 Camber Description and Business Overview

6.3.3 Camber Valsartan Tablets Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Camber Valsartan Tablets Product Portfolio

6.3.5 Camber Recent Developments/Updates

6.4 Major

6.4.1 Major Corporation Information

6.4.2 Major Description and Business Overview

6.4.3 Major Valsartan Tablets Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Major Valsartan Tablets Product Portfolio

6.4.5 Major Recent Developments/Updates

6.5 Mylan

6.5.1 Mylan Corporation Information

6.5.2 Mylan Description and Business Overview

6.5.3 Mylan Valsartan Tablets Sales, Revenue and Gross Margin (2019-2024)

6.5.4 Mylan Valsartan Tablets Product Portfolio

6.5.5 Mylan Recent Developments/Updates

6.6 Solco Healthcare

6.6.1 Solco Healthcare Corporation Information

6.6.2 Solco Healthcare Description and Business Overview

6.6.3 Solco Healthcare Valsartan Tablets Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Solco Healthcare Valsartan Tablets Product Portfolio

6.6.5 Solco Healthcare Recent Developments/Updates

6.7 Teva

6.6.1 Teva Corporation Information

6.6.2 Teva Description and Business Overview

6.6.3 Teva Valsartan Tablets Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Teva Valsartan Tablets Product Portfolio

6.7.5 Teva Recent Developments/Updates

6.8 Lupin

6.8.1 Lupin Corporation Information

6.8.2 Lupin Description and Business Overview

6.8.3 Lupin Valsartan Tablets Sales, Revenue and Gross Margin (2019-2024)

6.8.4 Lupin Valsartan Tablets Product Portfolio

6.8.5 Lupin Recent Developments/Updates

6.9 Repackagers

6.9.1 Repackagers Corporation Information

6.9.2 Repackagers Description and Business Overview

6.9.3 Repackagers Valsartan Tablets Sales, Revenue and Gross Margin (2019-2024)

6.9.4 Repackagers Valsartan Tablets Product Portfolio

6.9.5 Repackagers Recent Developments/Updates

6.10 Aurobindo

6.10.1 Aurobindo Corporation Information

6.10.2 Aurobindo Description and Business Overview

6.10.3 Aurobindo Valsartan Tablets Sales, Revenue and Gross Margin (2019-2024)

6.10.4 Aurobindo Valsartan Tablets Product Portfolio

6.10.5 Aurobindo Recent Developments/Updates

6.11 Zhejiang Huahai Pharm

6.11.1 Zhejiang Huahai Pharm Corporation Information

6.11.2 Zhejiang Huahai Pharm Valsartan Tablets Description and Business Overview

6.11.3 Zhejiang Huahai Pharm Valsartan Tablets Sales, Revenue and Gross Margin (2019-2024)

6.11.4 Zhejiang Huahai Pharm Valsartan Tablets Product Portfolio

6.11.5 Zhejiang Huahai Pharm Recent Developments/Updates

6.12 Changzhou Siyao Pharmaceutical

6.12.1 Changzhou Siyao Pharmaceutical Corporation Information

6.12.2 Changzhou Siyao Pharmaceutical Valsartan Tablets Description and Business Overview

6.12.3 Changzhou Siyao Pharmaceutical Valsartan Tablets Sales, Revenue and Gross Margin (2019-2024)

6.12.4 Changzhou Siyao Pharmaceutical Valsartan Tablets Product Portfolio

6.12.5 Changzhou Siyao Pharmaceutical Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Valsartan Tablets Industry Chain Analysis

7.2 Valsartan Tablets Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Valsartan Tablets Production Mode & Process

7.4 Valsartan Tablets Sales and Marketing

7.4.1 Valsartan Tablets Sales Channels

7.4.2 Valsartan Tablets Distributors

7.5 Valsartan Tablets Customers

8 Valsartan Tablets Market Dynamics

8.1 Valsartan Tablets Industry Trends

8.2 Valsartan Tablets Market Drivers

8.3 Valsartan Tablets Market Challenges

8.4 Valsartan Tablets Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Zhejiang Huahai Pharm

Changzhou Siyao Pharmaceutical

List of Tables

Table 1. Global Valsartan Tablets Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Valsartan Tablets Market Value Comparison by Application (2024-2030) & (US$ Million)

Table 3. Global Valsartan Tablets Market Competitive Situation by Manufacturers in 2023

Table 4. Global Valsartan Tablets Sales (K Units) of Key Manufacturers (2019-2024)

Table 5. Global Valsartan Tablets Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Valsartan Tablets Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Valsartan Tablets Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Valsartan Tablets Average Price (US$/Unit) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Valsartan Tablets, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Valsartan Tablets, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Valsartan Tablets, Product Type & Application

Table 12. Global Key Manufacturers of Valsartan Tablets, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Valsartan Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Valsartan Tablets as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Valsartan Tablets Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Valsartan Tablets Sales by Region (2019-2024) & (K Units)

Table 18. Global Valsartan Tablets Sales Market Share by Region (2019-2024)

Table 19. Global Valsartan Tablets Sales by Region (2025-2030) & (K Units)

Table 20. Global Valsartan Tablets Sales Market Share by Region (2025-2030)

Table 21. Global Valsartan Tablets Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Valsartan Tablets Revenue Market Share by Region (2019-2024)

Table 23. Global Valsartan Tablets Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Valsartan Tablets Revenue Market Share by Region (2025-2030)

Table 25. North America Valsartan Tablets Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Valsartan Tablets Sales by Country (2019-2024) & (K Units)

Table 27. North America Valsartan Tablets Sales by Country (2025-2030) & (K Units)

Table 28. North America Valsartan Tablets Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Valsartan Tablets Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Valsartan Tablets Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Valsartan Tablets Sales by Country (2019-2024) & (K Units)

Table 32. Europe Valsartan Tablets Sales by Country (2025-2030) & (K Units)

Table 33. Europe Valsartan Tablets Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Valsartan Tablets Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Valsartan Tablets Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Valsartan Tablets Sales by Region (2019-2024) & (K Units)

Table 37. Asia Pacific Valsartan Tablets Sales by Region (2025-2030) & (K Units)

Table 38. Asia Pacific Valsartan Tablets Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Valsartan Tablets Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Valsartan Tablets Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Valsartan Tablets Sales by Country (2019-2024) & (K Units)

Table 42. Latin America Valsartan Tablets Sales by Country (2025-2030) & (K Units)

Table 43. Latin America Valsartan Tablets Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Valsartan Tablets Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Valsartan Tablets Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa Valsartan Tablets Sales by Country (2019-2024) & (K Units)

Table 47. Middle East & Africa Valsartan Tablets Sales by Country (2025-2030) & (K Units)

Table 48. Middle East & Africa Valsartan Tablets Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Valsartan Tablets Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Valsartan Tablets Sales (K Units) by Type (2019-2024)

Table 51. Global Valsartan Tablets Sales (K Units) by Type (2025-2030)

Table 52. Global Valsartan Tablets Sales Market Share by Type (2019-2024)

Table 53. Global Valsartan Tablets Sales Market Share by Type (2025-2030)

Table 54. Global Valsartan Tablets Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Valsartan Tablets Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Valsartan Tablets Revenue Market Share by Type (2019-2024)

Table 57. Global Valsartan Tablets Revenue Market Share by Type (2025-2030)

Table 58. Global Valsartan Tablets Price (US$/Unit) by Type (2019-2024)

Table 59. Global Valsartan Tablets Price (US$/Unit) by Type (2025-2030)

Table 60. Global Valsartan Tablets Sales (K Units) by Application (2019-2024)

Table 61. Global Valsartan Tablets Sales (K Units) by Application (2025-2030)

Table 62. Global Valsartan Tablets Sales Market Share by Application (2019-2024)

Table 63. Global Valsartan Tablets Sales Market Share by Application (2025-2030)

Table 64. Global Valsartan Tablets Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Valsartan Tablets Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Valsartan Tablets Revenue Market Share by Application (2019-2024)

Table 67. Global Valsartan Tablets Revenue Market Share by Application (2025-2030)

Table 68. Global Valsartan Tablets Price (US$/Unit) by Application (2019-2024)

Table 69. Global Valsartan Tablets Price (US$/Unit) by Application (2025-2030)

Table 70. Alembic Corporation Information

Table 71. Alembic Description and Business Overview

Table 72. Alembic Valsartan Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 73. Alembic Valsartan Tablets Product

Table 74. Alembic Recent Developments/Updates

Table 75. Cadista Corporation Information

Table 76. Cadista Description and Business Overview

Table 77. Cadista Valsartan Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 78. Cadista Valsartan Tablets Product

Table 79. Cadista Recent Developments/Updates

Table 80. Camber Corporation Information

Table 81. Camber Description and Business Overview

Table 82. Camber Valsartan Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 83. Camber Valsartan Tablets Product

Table 84. Camber Recent Developments/Updates

Table 85. Major Corporation Information

Table 86. Major Description and Business Overview

Table 87. Major Valsartan Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 88. Major Valsartan Tablets Product

Table 89. Major Recent Developments/Updates

Table 90. Mylan Corporation Information

Table 91. Mylan Description and Business Overview

Table 92. Mylan Valsartan Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 93. Mylan Valsartan Tablets Product

Table 94. Mylan Recent Developments/Updates

Table 95. Solco Healthcare Corporation Information

Table 96. Solco Healthcare Description and Business Overview

Table 97. Solco Healthcare Valsartan Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 98. Solco Healthcare Valsartan Tablets Product

Table 99. Solco Healthcare Recent Developments/Updates

Table 100. Teva Corporation Information

Table 101. Teva Description and Business Overview

Table 102. Teva Valsartan Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 103. Teva Valsartan Tablets Product

Table 104. Teva Recent Developments/Updates

Table 105. Lupin Corporation Information

Table 106. Lupin Description and Business Overview

Table 107. Lupin Valsartan Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 108. Lupin Valsartan Tablets Product

Table 109. Lupin Recent Developments/Updates

Table 110. Repackagers Corporation Information

Table 111. Repackagers Description and Business Overview

Table 112. Repackagers Valsartan Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 113. Repackagers Valsartan Tablets Product

Table 114. Repackagers Recent Developments/Updates

Table 115. Aurobindo Corporation Information

Table 116. Aurobindo Description and Business Overview

Table 117. Aurobindo Valsartan Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 118. Aurobindo Valsartan Tablets Product

Table 119. Aurobindo Recent Developments/Updates

Table 120. Zhejiang Huahai Pharm Corporation Information

Table 121. Zhejiang Huahai Pharm Description and Business Overview

Table 122. Zhejiang Huahai Pharm Valsartan Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 123. Zhejiang Huahai Pharm Valsartan Tablets Product

Table 124. Zhejiang Huahai Pharm Recent Developments/Updates

Table 125. Changzhou Siyao Pharmaceutical Corporation Information

Table 126. Changzhou Siyao Pharmaceutical Description and Business Overview

Table 127. Changzhou Siyao Pharmaceutical Valsartan Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 128. Changzhou Siyao Pharmaceutical Valsartan Tablets Product

Table 129. Changzhou Siyao Pharmaceutical Recent Developments/Updates

Table 130. Key Raw Materials Lists

Table 131. Raw Materials Key Suppliers Lists

Table 132. Valsartan Tablets Distributors List

Table 133. Valsartan Tablets Customers List

Table 134. Valsartan Tablets Market Trends

Table 135. Valsartan Tablets Market Drivers

Table 136. Valsartan Tablets Market Challenges

Table 137. Valsartan Tablets Market Restraints

Table 138. Research Programs/Design for This Report

Table 139. Key Data Information from Secondary Sources

Table 140. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Valsartan Tablets

Figure 2. Global Valsartan Tablets Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Valsartan Tablets Market Share by Type in 2023 & 2030

Figure 4. 40mg Product Picture

Figure 5. 80mg Product Picture

Figure 6. 160mg Product Picture

Figure 7. 320mg Product Picture

Figure 8. Global Valsartan Tablets Market Value Comparison by Application (2024-2030) & (US$ Million)

Figure 9. Global Valsartan Tablets Market Share by Application in 2023 & 2030

Figure 10. Hospital

Figure 11. Clinic

Figure 12. Recovery Center

Figure 13. Global Valsartan Tablets Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 14. Global Valsartan Tablets Market Size (2019-2030) & (US$ Million)

Figure 15. Global Valsartan Tablets Sales (2019-2030) & (K Units)

Figure 16. Global Valsartan Tablets Average Price (US$/Unit) & (2019-2030)

Figure 17. Valsartan Tablets Report Years Considered

Figure 18. Valsartan Tablets Sales Share by Manufacturers in 2023

Figure 19. Global Valsartan Tablets Revenue Share by Manufacturers in 2023

Figure 20. The Global 5 and 10 Largest Valsartan Tablets Players: Market Share by Revenue in 2023

Figure 21. Valsartan Tablets Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 22. Global Valsartan Tablets Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 23. North America Valsartan Tablets Sales Market Share by Country (2019-2030)

Figure 24. North America Valsartan Tablets Revenue Market Share by Country (2019-2030)

Figure 25. U.S. Valsartan Tablets Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 26. Canada Valsartan Tablets Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 27. Europe Valsartan Tablets Sales Market Share by Country (2019-2030)

Figure 28. Europe Valsartan Tablets Revenue Market Share by Country (2019-2030)

Figure 29. Germany Valsartan Tablets Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. France Valsartan Tablets Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. U.K. Valsartan Tablets Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. Italy Valsartan Tablets Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 33. Russia Valsartan Tablets Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 34. Asia Pacific Valsartan Tablets Sales Market Share by Region (2019-2030)

Figure 35. Asia Pacific Valsartan Tablets Revenue Market Share by Region (2019-2030)

Figure 36. China Valsartan Tablets Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. Japan Valsartan Tablets Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. South Korea Valsartan Tablets Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. India Valsartan Tablets Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. Australia Valsartan Tablets Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. Taiwan Valsartan Tablets Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. Indonesia Valsartan Tablets Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. Thailand Valsartan Tablets Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Malaysia Valsartan Tablets Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Philippines Valsartan Tablets Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 46. Latin America Valsartan Tablets Sales Market Share by Country (2019-2030)

Figure 47. Latin America Valsartan Tablets Revenue Market Share by Country (2019-2030)

Figure 48. Mexico Valsartan Tablets Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 49. Brazil Valsartan Tablets Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 50. Argentina Valsartan Tablets Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 51. Middle East & Africa Valsartan Tablets Sales Market Share by Country (2019-2030)

Figure 52. Middle East & Africa Valsartan Tablets Revenue Market Share by Country (2019-2030)

Figure 53. Turkey Valsartan Tablets Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 54. Saudi Arabia Valsartan Tablets Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 55. UAE Valsartan Tablets Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 56. Global Sales Market Share of Valsartan Tablets by Type (2019-2030)

Figure 57. Global Revenue Market Share of Valsartan Tablets by Type (2019-2030)

Figure 58. Global Valsartan Tablets Price (US$/Unit) by Type (2019-2030)

Figure 59. Global Sales Market Share of Valsartan Tablets by Application (2019-2030)

Figure 60. Global Revenue Market Share of Valsartan Tablets by Application (2019-2030)

Figure 61. Global Valsartan Tablets Price (US$/Unit) by Application (2019-2030)

Figure 62. Valsartan Tablets Value Chain

Figure 63. Valsartan Tablets Production Process

Figure 64. Channels of Distribution (Direct Vs Distribution)

Figure 65. Distributors Profiles

Figure 66. Bottom-up and Top-down Approaches for This Report

Figure 67. Data Triangulation

Figure 68. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions